Synopsis: On 31 December 2025, Privi Speciality Chemicals Limited saw a major bulk deal as SBI Mutual Fund bought a 5.73% stake, while Vivira Investment exited 9.28% equity.
This Chemical stock, engaged in manufacturing, supplying, and exporting aroma and fragrance chemicals like ionones, citral, and specialty musks for personal care, detergents, and fine fragrances, jumped 1.12 percent after SBI Mutual Fund acquired a 5.73 percent stake in the company.
With a market capitalization of Rs. 10,984.24 crores, the share of Privi Speciality Chemicals Limited has reached an intraday high of Rs. 2,835.50 per equity share, rising nearly 1.12 percent from its previous day’s close price of Rs. 2,804.15.
Since then, the stock has retreated and is currently trading at Rs. 2,818.65 per equity share. Privi Speciality Chemicals Limited is currently down by 17.90 percent from the 52-week high of Rs. 3,433.
On 31 December 2025, Privi Speciality Chemicals Limited witnessed a major bulk deal, led by buying activity from SBI Mutual Fund. SBI Mutual Fund acquired 22,40,000 shares, representing 5.73 percent equity, at an average price of Rs. 2,833.96 per share. The total value of this purchase was approximately Rs. 634.81 crore, reflecting strong institutional confidence in the company’s growth outlook.
Following this transaction, SBI Mutual Fund’s total holding increased significantly. As of September 2025, SBI Multi Asset Allocation Fund held 14,22,721 shares (3.64 percent) in the company. With the latest acquisition, SBI Group’s Mutual Fund’s cumulative holding rose to 36,62,721 shares, translating to an overall 9.38 percent stake in Privi Speciality Chemicals.
On the selling side, Vivira Investment & Trading Private Limited sold 36,28,627 shares (9.28 percent) at an average price of Rs. 2,838 per share, with a transaction value of around Rs. 1,029.80 crore.
Prior to the sale, Vivira Investment & Trading Private Limited held 1,52,45,188 shares (39.03 percent). Following this transaction, its holding was reduced to 1,16,16,561 shares, equivalent to about a 29.74 percent stake, while still remaining a significant promoter-level investor in the company.
Current Capacity:
Privi Speciality Chemicals Limited has a strong capacity base with 48,000 MTPA production capacity, 36,000 MTPA CST processing capacity, and 9,600 MTPA GTO processing capacity across 7 state-of-the-art facilities, offering more than 75 products in over 40 countries.
The company’s development is driven by 2 dedicated R&D centers, continuous innovation, global client partnerships, and a focus on sustainable, high-quality specialty chemical solutions.
Client Base:
Privi Speciality Chemicals Limited has a strong and diversified global client base, serving leading international fragrance houses and FMCG majors. Its customers include renowned names such as Givaudan, Firmenich, IFF, Symrise, MANE, Takasago, Robertet, Drom Fragrances, Keva, P&G, Henkel, Reckitt Benckiser, BASF, and AkzoNobel, among others
Recent Quarter Results:
In terms of financial highlights, Privi Speciality Chemicals Limited reported revenue of Rs. 679 crore for Q2 FY26, reflecting a YoY growth of 27.39 percent. Additionally, the net profit doubled compared to the previous year, reaching Rs. 90 crore in Q2 FY26. Privi Speciality Chemicals Limited’s revenue and net profit have grown at a CAGR of 14.38 percent and 24.01 percent, respectively, over the last three years.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
